Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "L02BB" (29)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Bicalutamide (L02BB03) 20 products
WHO-DDD
DrugBank.ca
IP
CI
Casodex 50 mg
-
T
30 Tablet(s)
84.42
107.70
20 %
Coated tablets: Bicalutamidum 50 mg
Medius AG
B / SL / SO
FB
G
IP
CI
Casodex 50 mg
-
T
100 Tablet(s)
160.85
191.30
20 %
Coated tablets: Bicalutamidum 50 mg
Medius AG
B / SL / SO
FB
G
IP
CI
Casodex 150 mg
30 Tablet(s)
175.09
204.55
10 %
Coated tablets: Bicalutamidum 150 mg
Medius AG
B / SL / SO
FB
G
IP
CI
Casodex 150 mg
100 Tablet(s)
295.46
337.55
10 %
Coated tablets: Bicalutamidum 150 mg
Medius AG
B / SL / SO
FB
G
IP
CI
Bicalutamid Sandoz eco 50 mg
30 Tablet(s)
75.98
99.05
10 %
Coated tablets: Bicalutamidum 50 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Bicalutamid Sandoz eco 50 mg
100 Tablet(s)
160.00
190.40
10 %
Coated tablets: Bicalutamidum 50 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Bicalutamid Sandoz eco 150 mg
30 Tablet(s)
138.16
166.65
10 %
Coated tablets: Bicalutamidum 150 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Bicalutamid Sandoz eco 150 mg
100 Tablet(s)
292.13
334.10
10 %
Coated tablets: Bicalutamidum 150 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Bicalutamid Zentiva 50 mg
30
75.98
99.05
10 %
Coated tablets: Bicalutamidum 50 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Bicalutamid Zentiva 50 mg
100
160.00
190.40
10 %
Coated tablets: Bicalutamidum 50 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Bicalutamid Zentiva 150 mg
30
138.16
166.65
10 %
Coated tablets: Bicalutamidum 150 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Bicalutamid Zentiva 150 mg
100
292.13
334.10
10 %
Coated tablets: Bicalutamidum 150 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Bicalutamid-Teva 50 mg
30 Tablet(s)
75.98
99.05
10 %
Coated tablets: Bicalutamidum 50 mg
Teva Pharma AG
B / SL / SG
FB
G
IP
CI
Bicalutamid-Teva 50 mg
100 Tablet(s)
159.23
189.60
10 %
Coated tablets: Bicalutamidum 50 mg
Teva Pharma AG
B / SL / SG
FB
G
IP
CI
Bicalutamid-Teva 150 mg
30 Tablet(s)
138.16
166.65
10 %
Coated tablets: Bicalutamidum 150 mg
Teva Pharma AG
B / SL / SG
FB
G
IP
CI
Bicalutamid-Teva 150 mg
100 Tablet(s)
292.13
334.10
10 %
Coated tablets: Bicalutamidum 150 mg
Teva Pharma AG
B / SL / SG
FB
G
IP
CI
Bicalutamid Sandoz 50 mg
30 Tablet(s)
90.40
120.20
k.A.
Coated tablets: Bicalutamidum 50 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Bicalutamid Sandoz 50 mg
100 Tablet(s)
287.11
346.00
k.A.
Coated tablets: Bicalutamidum 50 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Bicalutamid Sandoz 150 mg
30 Tablet(s)
185.52
229.40
k.A.
Coated tablets: Bicalutamidum 150 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Bicalutamid Sandoz 150 mg
100 Tablet(s)
521.81
615.45
k.A.
Coated tablets: Bicalutamidum 150 mg
Sandoz
Pharmaceuticals AG
B
FB
G
Enzalutamide (L02BB04) 6 products
WHO-DDD
DrugBank.ca
Enzalutamid Sandoz 40 mg
112
PR
PR
k.A.
Coated tablets: Enzalutamidum 40 mg
Sandoz
Pharmaceuticals AG
B
FB
G
Enzalutamid Sandoz 80 mg
56
PR
PR
k.A.
Coated tablets: Enzalutamidum 80 mg
Sandoz
Pharmaceuticals AG
B
FB
G
Enzalutamid Spirig HC 40 mg
112
PR
PR
k.A.
Coated tablets: Enzalutamidum 40 mg
Spirig HealthCare AG
B
FB
G
Enzalutamid Spirig HC 80 mg
56
PR
PR
k.A.
Coated tablets: Enzalutamidum 80 mg
Spirig HealthCare AG
B
FB
G
L
IP
CI
Xtandi 40 mg
112
2869.93
3137.65
10 %
Coated tablets: Enzalutamidum 40 mg
Astellas Pharma AG
B / SL
FB
G
IP
Xtandi 80 mg
56
PR
PR
k.A.
Coated tablets: Enzalutamidum 80 mg
Astellas Pharma AG
B
FB
G
Apalutamide (L02BB05) 2 products
WHO-DDD
L
IP
Erleada 240 mg
2 x 14
3006.28
3285.95
10 %
Coated tablets: Apalutamidum 240 mg
Janssen-Cilag AG
B / SL
FB
G
L
IP
CI
Erleada 60 mg
4 x 28
3006.28
3285.95
10 %
Coated tablets: Apalutamidum 60 mg
Janssen-Cilag AG
B / SL
FB
G
Darolutamide (L02BB06) 1 products
WHO-DDD
L
IP
CI
NUBEQA 300 mg
112
2930.21
3203.20
10 %
Coated tablets: Darolutamidum 300 mg
Bayer (Schweiz) AG
B / SL
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
